Nomogram Using Optical Coherence Tomography and Visual Field Parameters to Predict Brain Lesions in Patients with Bitemporal Hemianopia

References

• Shikishima K, Kitahara K, Mizobuchi T, Yoshida M. Interpretation of visual field defects respecting the vertical meridian and not related to distinct chiasmal or postchiasmal lesions. J Clin Neurosci. 2006;13:923–28. doi:10.1016/j.jocn.2005.11.047.
   PubMed Web of Science ®Google Scholar
• Peli E, Satgunam P. Bitemporal hemianopia; its unique binocular complexities and a novel remedy. Ophthalmic Physiol Opt. 2014;34:233–42. doi:10.1111/opo.12118.
   PubMed Web of Science ®Google Scholar
• Hershenfeld SA, Sharpe JA. Monocular temporal hemianopia. Br J Ophthalmol. 1993;77:424–27.
   PubMed Web of Science ®Google Scholar
• Johnson LN, Rabinowitz YS, Hepler RS. Hemianopia respecting the vertical meridian and with foveal sparing from retinal degeneration. Neurology. 1989;39:872–73.
   PubMed Web of Science ®Google Scholar
• Woung LC, Jou JR, Liaw SL. Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1995;11:411–19. doi:10.1089/jop.1995.11.411.
   PubMed Web of Science ®Google Scholar
• Savino PJ, Glaser JS, Schatz NJ. Traumatic chiasmal syndrome. Neurology. 1980;30:963–70.
   PubMed Web of Science ®Google Scholar
• Newman NJ, Lessell S, Winterkorn JM. Optic chiasmal neuritis. Neurology. 1991;41:1203–10.
   PubMed Web of Science ®Google Scholar
• Kho RC, Al-Obailan M, Arnold AC. Bitemporal visual field defects in ethambutol-induced optic neuropathy. J Neuroophthalmol. 2011;31:121–26. doi:10.1097/WNO.0b013e318205a148.
   PubMed Web of Science ®Google Scholar
• Keltner JL, Johnson CA, Spurr JO, Beck RW. Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1994;112:946–53.
   PubMedGoogle Scholar
• Thompson JC, Kosmorsky GS, Ellis BD. Field of dreamers and dreamed-up fields: functional and fake perimetry. Ophthalmology. 1996;103:117–25.
   PubMed Web of Science ®Google Scholar
• Palmowski AM, Fischer A, Ruprecht KW. Multifocal examination techniques in malingering: case report of a patient with monocular vertical hemianopia. Graefes Arch Clin Exp Ophthalmol. 2003;241:70–71. doi:10.1007/s00417-002-0594-4.
   PubMed Web of Science ®Google Scholar
• Hood DC, Zhang X, Greenstein VC, Kangovi S, Odel JG, Liebmann JM, Ritch R. An interocular comparison of the multifocal VEP: a possible technique for detecting local damage to the optic nerve. Invest Ophthalmol Vis Sci. 2000;41:1580–87.
   PubMed Web of Science ®Google Scholar
• Klistorner AI, Graham SL, Grigg JR, Billson FA. Multifocal topographic visual evoked potential: improving objective detection of local visual field defects. Invest Ophthalmol Vis Sci. 1998;39:937–50.
   PubMed Web of Science ®Google Scholar
• Jeong AR, Kim EY, Kim NR. Preferential Ganglion cell loss in the nasal hemiretina in patients with pituitary Tumor. J Neuroophthalmol. 2016;36:152–55. doi:10.1097/WNO.0000000000000331.
   PubMed Web of Science ®Google Scholar
• Monteiro ML, Costa-Cunha LV, Cunha LP, Malta RF. Correlation between macular and retinal nerve fibre layer Fourier-domain OCT measurements and visual field loss in chiasmal compression. Eye (Lond). 2010;24:1382–90. doi:10.1038/eye.2010.48.
   PubMed Web of Science ®Google Scholar
• Monteiro ML, Hokazono K, Fernandes DB, Costa-Cunha LV, Sousa RM, Raza AS, Wang DL, Hood DC. Evaluation of inner retinal layers in eyes with temporal hemianopic visual loss from chiasmal compression using optical coherence tomography. Invest Ophthalmol Vis Sci. 2014;55:3328–36. doi:10.1167/iovs.14-14118.
   PubMed Web of Science ®Google Scholar
• Yum HR, Park SH, Park HY, Shin SY. Macular Ganglion cell analysis determined by cirrus HD optical coherence tomography for early detecting chiasmal compression. PLoS One. 2016;11:e0153064. doi:10.1371/journal.pone.0153064.
   PubMed Web of Science ®Google Scholar
• Shin HY, Park HY, Choi JA, Park CK. Macular ganglion cell-inner plexiform layer thinning in patients with visual field defect that respects the vertical meridian. Graefes Arch Clin Exp Ophthalmol. 2014;252:1501–07. doi:10.1007/s00417-014-2706-3.
   PubMed Web of Science ®Google Scholar
• Moon H, Yoon JY, Lim HT, Sung KR. Ganglion cell and inner plexiform layer thickness determined by spectral domain optical coherence tomography in patients with brain lesions. Br J Ophthalmol. 2015;99:329–35. doi:10.1136/bjophthalmol-2014-305361.
   PubMed Web of Science ®Google Scholar
• Katz J, Sommer A, Gaasterland DE, Anderson DR. Comparison of analytic algorithms for detecting glaucomatous visual field loss. Arch Ophthalmol. 1991;109:1684–89.
   PubMedGoogle Scholar
• Costa-Cunha LV, Cunha LP, Malta RF, Monteiro ML. Comparison of Fourier-domain and time-domain optical coherence tomography in the detection of band atrophy of the optic nerve. Am J Ophthalmol. 2009;147:56–63.e52. doi:10.1016/j.ajo.2008.07.020.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Stein DM, Wollstein G, Beaton S, Fujimoto JG, Schuman JS. Macular segmentation with optical coherence tomography. Invest Ophthalmol Vis Sci. 2005;46:2012–17. doi:10.1167/iovs.04-0335.
   PubMed Web of Science ®Google Scholar
• Mwanza JC, Oakley JD, Budenz DL, Chang RT, Knight OJ, Feuer WJ. Macular ganglion cell-inner plexiform layer: automated detection and thickness reproducibility with spectral domain-optical coherence tomography in glaucoma. Invest Ophthalmol Vis Sci. 2011;52:8323–29. doi:10.1167/iovs.11-7962.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990;300:5–25. doi:10.1002/cne.903000103.
   PubMed Web of Science ®Google Scholar
• Smith JL, Hoyt WF, Susac JO. Ocular fundus in acute Leber optic neuropathy. Arch Ophthalmol. 1973;90:349–54.
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Griffiths PG, Burke A, Sellar PW, Clarke MP, Gnanaraj L, Ah-Kine D, Hudson G, Czermin B, Taylor RW, et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology. 2010;117(1538–1546):1546.e1531. doi:10.1016/j.ophtha.2009.12.038.
   PubMedGoogle Scholar
• Yu-Wai-Man P, Trenell MI, Hollingsworth KG, Griffiths PG, Chinnery PF. OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy. Brain. 2011;134:e164. doi:10.1093/brain/awr044.
   PubMed Web of Science ®Google Scholar
• Votruba M, Moore AT, Bhattacharya SS. Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. J Med Genet. 1998;35:793–800.
   PubMed Web of Science ®Google Scholar
• Barboni P, Carbonelli M, Savini G, Foscarini B, Parisi V, Valentino ML, Carta A, De Negri A, Sadun F, Zeviani M, et al. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size. Ophthalmology. 2010;117:1547–53. doi:10.1016/j.ophtha.2009.12.042.
   PubMed Web of Science ®Google Scholar
• Nikoskelainen E, Hoyt WF, Nummelin K. Ophthalmoscopic findings in Leber’s hereditary optic neuropathy. II. The fundus findings in the affected family members. Arch Ophthalmol. 1983;101:1059–68.
   PubMedGoogle Scholar
• Lim SA. Ethambutol-associated optic neuropathy. Ann Acad Med Singapore. 2006;35:274–78.
   PubMed Web of Science ®Google Scholar
• Schmidt IG. Central nervous system effects of ethambutol in monkeys. Ann N Y Acad Sci. 1966;135:759–74.
   PubMed Web of Science ®Google Scholar
• Lessell S. Histopathology of experimental ethambutol intoxication. Invest Ophthalmol Vis Sci. 1976;15:765–69.
   PubMed Web of Science ®Google Scholar
• Beck RW, Gal RL, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, et al. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol. 2004;137:77–83.
   PubMed Web of Science ®Google Scholar
• Beck RW, Cleary PA, Anderson MM, Jr., Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The optic neuritis study group. N Engl J Med. 1992;326:581–88. doi:10.1056/NEJM199202273260901.
   PubMed Web of Science ®Google Scholar
• Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH, Optic Neuritis Study Group. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The optic neuritis study group. N Engl J Med. 1993;329:1764–69. doi:10.1056/NEJM199312093292403.
   PubMed Web of Science ®Google Scholar
• Cleary PA, Beck RW, Anderson MM Jr., Kenny DJ, Backlund JY, Gilbert PR. Design, methods, and conduct of the optic neuritis treatment trial. Control Clin Trials. 1993;14:123–42.
   PubMedGoogle Scholar